Business article 701 Views Business Interview: At the forefront of clinical cell therapy Malin Otmani May 18, 2022 XNK Therapeutics recently secured a …
In a new job 602 Views Ted Fjällman is a new board member at XNK Therapeutics Malin Otmani May 10, 2022 XNK Therapeutics has announced that …
Biotech Business 649 Views XNK Therapeutics raises 132 million SEK Malin Otmani March 29, 2022 The company has secured a …
Clinical Trials 461 Views First patient treated in XNK Therapeutics study Malin Otmani March 23, 2022 XNK Therapeutics has announced that …
Clinical Trials 457 Views XNK Therapeutics phase I study published Malin Otmani February 21, 2022 XNK Therapeutics has announced that …
In a new job 351 Views XNK Therapeutics adds three scientific advisors Malin Otmani November 22, 2021 XNK Therapeutics has announced the …
Biotech Business 590 Views XNK Therapeutics further expands its pipeline Malin Otmani September 29, 2021 XNK Therapeutics has announced plans …
Clinical Trials 765 Views First patient included in XNK trial Malin Otmani July 2, 2021 XNK Therapeutics has announced that …
Clinical Trials 776 Views XNK Therapeutics enters joint Phase II study Malin Otmani February 26, 2021 XNK Therapeutics is entering into …
Pharma Business 992 Views XNK Therapeutics receives US orphan drug status Malin Otmani November 5, 2020 XNK Therapeutics has received Orphan …
